NEW YORK, Feb. 3 - Ingenium Pharmaceuticals has signed an agreement with the GermanNationalResearchCenter for Environment and Health (GSF) to add GSF's tissue archive to its own archive for genotyping, the company said today.
This agreement doubles Ingenium's archive, according to the company.
Ingenium, of Munich, uses this archive for its Ingenotyping technology, which produces murine models with point mutations in genes for target validation in drug discovery. The company has close ties to GSF. The director of GSF's institute of experimental genetics, Martin Hrabe, is a scientific founder.
Hrabe said in a statement that the archive represents "seven years of murine genetic research conducted at the GSF."